Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

CDP is crucial for lung and hair follicle cell development.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Hair loss linked to higher heart disease risk in both men and women.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

p63 is essential for controlling epithelial stem cells and tissue health.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.